ClarVista Medical says it pulled in $14 million in a Series B round for its new intraocular lens replacement used after cataract surgery.
California startup ClarVista Medical said it raised a $14 million Series B round slated for development of its adjustable post-cataract surgery intraocular lens replacement. Cycad Group and Windham Venture Partners co-led the round, along with existing investor New Enterprise Associates, ClarVista said.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1HHR7mN
Cap comentari:
Publica un comentari a l'entrada